APR 10, 2019 10:30 AM PDT

Better Knowledge, Better Care: Precision Medicine for Any Cancer, Any Assay, on Your Platform

Sponsored by: QIAGEN
C.E. Credits: P.A.C.E. CE Florida CE
Speakers
  • Chief Scientific Officer, N-of-One, A QIAGEN Company
    Biography
      Sheryl Krevsky Elkin, PhD, is the Chief Scientific Officer at N-of-One. As an early member of the N-of-One team, Dr. Elkin has led the interpretation of thousands of patient cases, establishing a rigorous process for the analysis of scientific and clinical evidence and presentation of molecular and clinical evidence to physicians to help guide their therapeutic decisions. For the past nine years, Dr. Elkin has taken a lead role in the development of the N-of-One clinical interpretation methodology to support clinicians in identifying therapeutic strategies specific to each patient. Prior to joining N-of-One, Dr. Elkin completed her postdoctoral fellowship at the Massachusetts Institute of Technology's Center for Cancer Research, where she earned a fellowship from the Leukemia and Lymphoma Society. Dr. Elkin earned her doctorate in Biological and Biomedical Sciences from Harvard Medical School and an A.B. in Biology and Music from Amherst College, graduating Phi Beta Kappa and summa cum laude, with High Distinction in Biology.
    • Vice President, Biomedical Informatics, QIAGEN
      Biography
        Dan Richards is Vice President, Biomedical Informatics at QIAGEN, where he focuses on the automated interpretation of molecular variation in the context of current clinical evidence. Dan earned his Ph.D. in Human Genetics from Stanford University and co-founded Ingenuity Systems, whose analysis applications and manually-curated knowledge base of peer-reviewed scientific literature are used by scientists and clinicians worldwide to interpret genomic data in the context of current biomedical knowledge.

      Abstract

      QIAGEN helps your team focus on the opportunities, not the obstacles, with an end-to-end clinical testing solution. During this talk, we will present our clinical decision support solutions, QIAGEN Clinical Insight and N-of-One, that allow you to optimize and scale your pipeline for clinical interpretation of genetic variants—from sequence data to report sign-off—without sacrificing accuracy. With the automated implementation of expert guidelines for pathogenicity and actionability based on an expansive knowledgebase derived from >20 years of manual curation, and now with N-of-One bringing in report-ready text tailored to the assay, supporting the clinical options with the most relevant evidence from the literature, QIAGEN provides a platform that provides the best-in-class evidence enabling clarity and confidence in reporting.

      Learning Objectives: 

      1. Struggling to keep pace with the latest clinical findings? Learn how you can remain up-to-date on the increasing number of publications, biomarker data, and remain informed of changing clinical trial availability and treatment options with the combined QIAGEN Knowledge Base and N-of-One’s MarkerMine, now the world’s largest clinical evidence database providing the most relevant and timely information needed in your clinical decision making. 
      2. Looking for an automated NGS variant interpretation and reporting solution? Discover how to automate, scale and standardize your NGS variant interpretation and reporting according to the latest professional guidelines (ACMG/AMP, AMP/ASCO/CAP, etc.)
      3. Learn about the flexible options for standardized and consistent clinical NGS reporting that suits your needs


      Show Resources
      You May Also Like
      AUG 25, 2020 8:00 AM PDT
      C.E. CREDITS
      AUG 25, 2020 8:00 AM PDT
      DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
      JUN 09, 2020 10:00 AM PDT
      C.E. CREDITS
      JUN 09, 2020 10:00 AM PDT
      DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
      NOV 16, 2020 8:00 AM PST
      C.E. CREDITS
      NOV 16, 2020 8:00 AM PST
      Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
      OCT 29, 2020 6:00 AM PDT
      C.E. CREDITS
      OCT 29, 2020 6:00 AM PDT
      Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
      JUL 22, 2020 10:00 AM PDT
      C.E. CREDITS
      JUL 22, 2020 10:00 AM PDT
      DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
      SEP 10, 2020 9:00 AM PDT
      C.E. CREDITS
      SEP 10, 2020 9:00 AM PDT
      Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
      Loading Comments...
      Show Resources
      Attendees
      • See more